Disclosures for "Design of a Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Nipocalimab in Participants with Active Idiopathic Inflammatory Myopathies (SPIREA)")
-
Dr. Najem has received personal compensation for serving as an employee of Janssen R&D US.
-
Ms. Craig has nothing to disclose.
-
Lisa Christopher-Stine has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Lisa Christopher-Stine has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma . Lisa Christopher-Stine has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapitics. Lisa Christopher-Stine has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allogene. Lisa Christopher-Stine has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Lisa Christopher-Stine has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Borhringer-Ingelheim. Lisa Christopher-Stine has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD-Serono . Lisa Christopher-Stine has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Steritas. Lisa Christopher-Stine has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Arthritis and Rheumatology. The institution of Lisa Christopher-Stine has received research support from Myositis Association. Lisa Christopher-Stine has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Zazzetti has received personal compensation for serving as an employee of Janssen LLC.
-
Mr. Noel has received personal compensation for serving as an employee of Janssen. Mr. Noel has stock in Janssen.
-
Dr. Ramchandren has received personal compensation for serving as an employee of Janssen Pharmaceutical Companies of Johnson & Johnson. Dr. Ramchandren has a non-compensated relationship as a Scientific Advisory Board Member with CMT Research Foundation (CMTRF) that is relevant to AAN interests or activities.
-
Mr. Blango has nothing to disclose.
-
Dr. Karyekar has received personal compensation for serving as an employee of Janssen Pharmaceuticals. An immediate family member of Dr. Karyekar has received personal compensation for serving as an employee of Gilead Pharmaceuticals. Dr. Karyekar has stock in Janssen Pharmaceuticals. An immediate family member of Dr. Karyekar has stock in Gilead Pharmaceuticals.
-
Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kezar. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenex. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BI. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Q32. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Corbus. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. The institution of Dr. Aggarwal has received research support from Genentech. The institution of Dr. Aggarwal has received research support from Mallinckodt. The institution of Dr. Aggarwal has received research support from BMS. The institution of Dr. Aggarwal has received research support from EMD Serono. The institution of Dr. Aggarwal has received research support from Q32.